home · filing · 0001564590-21-037977
8-K
filed July 26, 2021, 7:59 PM ET
ticker HSDT
CIK 0001610853
leadership
confidence high
sentiment neutral
materiality 0.40
COO Joyce LaViscount departs Helius Medical Technologies effective July 20
Solana Co
Joyce LaViscount's employment as Chief Operating Officer ended on July 20, 2021.
No reason for the departure was disclosed in the filing.
No replacement or interim COO has been announced.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Departed
Joyce LaViscount
Chief Operating Officer
Effective 2021-07-20
Filed July 26, 2021, 7:59 PM ET
The employment of Joyce LaViscount, Chief Operating Officer of Helius Medical Technologies, Inc. ended on July 20, 2021.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Joyce LaViscount departed as Chief Operating Officer at Solana Co.
Action ended
Role Chief Operating Officer
Exact text from the filing
The employment of Joyce LaViscount, Chief Operating Officer of Helius Medical Technologies, Inc. ended on July 20, 2021.
View on SEC.gov
Source: SEC EDGAR
accession 0001564590-21-037977
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.